Middle East & Africa Gene Expression Market Size & Outlook
Middle East & Africa gene expression market, 2018-2030 (US$M)
Related Markets
MEA gene expression market highlights
- The MEA gene expression market generated a revenue of USD 367.0 million in 2022.
- The market is expected to grow at a CAGR of 2.3% from 2023 to 2030.
- In terms of segment, cdna synthesis & conversion was the largest revenue generating process in 2022.
- Data Analysis & Interpretation is the most lucrative process segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2023 to 2030.
MEA data book summary
| Market revenue in 2022 | USD 367.0 million |
| Market revenue in 2030 | USD 439.4 million |
| Growth rate | 2.3% (CAGR from 2022 to 2030) |
| Largest segment | Cdna synthesis & conversion |
| Fastest growing segment | Data Analysis & Interpretation |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sample Collection, Purification, CDNA Synthesis & Conversion, PCR Analysis, Data Analysis & Interpretation |
| Key market players worldwide | Catalent Inc, Qiagen NV, Quest Diagnostics Inc, Roche, Illumina Inc, PerkinElmer, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Agilent Technologies, GE HealthCare Technologies Inc Common Stock, Promega, Luminex, Takara Bio Inc, Danaher Corp |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.6% of the global gene expression market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,754.4 million by 2030.
Key Regions: U.S. , UK , Japan , Brazil , South Africa
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gene Expression Market Scope
Gene Expression Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa gene expression market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene expression market will help companies and investors design strategic landscapes.
Cdna synthesis & conversion was the largest segment with a revenue share of 26.95% in 2022. Horizon Databook has segmented the Middle East & Africa gene expression market based on sample collection, purification, cdna synthesis & conversion, pcr analysis, data analysis & interpretation covering the revenue growth of each sub-segment from 2018 to 2030.
Middle East & Africa held the lowest share in revenue in 2017. This can be attributed to lack of large-scale omics research in the region, lack of skilled personnel & expertise, and limited computational resources & infrastructure to conduct genomic research.
Government investments in this region are focused on providing basic needs and improving community health. Thus, funds for large-scale omics research and advanced clinical diagnostics & healthcare are unavailable. Hence, the Middle East & African countries are expected to register limited growth.
Reasons to subscribe to Middle East & Africa gene expression market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa gene expression market databook
-
Our clientele includes a mix of gene expression market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa gene expression market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa gene expression market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA gene expression analysis market size, by country, 2018-2030 (US$M)
Middle East & Africa Gene Expression Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
